Tixagevimab-cilgavimab Preexposure Prophylaxis in Solid Organ Transplant Recipients Is Associated With Fewer Breakthrough SARS-CoV-2 Infections, Except During the BA.5 Period.

Al Jurdi, Ayman; Morena, Leela; Verhoeff, Rucháma; Alzahrani, Nora; Kotton, Camille N; Riella, Leonardo V

Al Jurdi, Ayman; Morena, Leela; Verhoeff, Rucháma; Alzahrani, Nora; Kotton, Camille N; Riella, Leonardo V.

Afiliação

Al Jurdi A; Department of Surgery, Center for Transplantation Sciences, Massachusetts General Hospital, Boston, MA.
Morena L; Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Boston, MA.
Verhoeff R; Department of Surgery, Center for Transplantation Sciences, Massachusetts General Hospital, Boston, MA.
Alzahrani N; Department of Surgery, Center for Transplantation Sciences, Massachusetts General Hospital, Boston, MA.
Kotton CN; Department of Surgery, Center for Transplantation Sciences, Massachusetts General Hospital, Boston, MA.
Riella LV; Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Boston, MA.

Transplantation ; 107(9): e238-e240, 2023 09 01.

Article em En | MEDLINE | ID: mdl-37271875

Assuntos

COVID-19; Transplante de Órgãos; Humanos; COVID-19/prevenção & controle; SARS-CoV-2; Transplante de Órgãos/efeitos adversos; Transplantados

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: Transplante de Órgãos / COVID-19 Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Transplantation Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google